Ascendis Health (JSE:ASC) Total Liabilities : R408 Mil (As of Jun. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Ascendis Health Total Liabilities?

Ascendis Health's Total Liabilities for the quarter that ended in Jun. 2023 was R408 Mil.

Ascendis Health's quarterly Total Liabilities declined from Jun. 2022 (R1,275.80 Mil) to Dec. 2022 (R702.94 Mil) and declined from Dec. 2022 (R702.94 Mil) to Jun. 2023 (R407.81 Mil).

Ascendis Health's annual Total Liabilities declined from Jun. 2021 (R10,121.20 Mil) to Jun. 2022 (R1,275.80 Mil) and declined from Jun. 2022 (R1,275.80 Mil) to Jun. 2023 (R407.81 Mil).

Ascendis Health Total Liabilities Historical Data

The historical data trend for Ascendis Health's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Health Total Liabilities Chart

Ascendis Health Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Liabilities

Get a 7-Day Free Trial

9,212.13

10,822.12

10,121.20

1,275.80

407.81

Ascendis Health Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Liabilities	Get a 7-Day Free Trial															10,121.20	1,330.88	1,275.80	702.94	407.81

Ascendis Health Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ascendis Health's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	380.409	+	(19.306	+	8.099
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	408

Total Liabilities	=	Total Assets (A: Jun. 2023 )	-	Total Equity (A: Jun. 2023 )
	=	970.711	-	562.897
	=	408

Ascendis Health's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	380.409	+	(19.306	+	8.099
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	408

Total Liabilities	=	Total Assets (Q: Jun. 2023 )	-	Total Equity (Q: Jun. 2023 )
	=	970.711	-	562.897
	=	408

Ascendis Health Total Liabilities Related Terms

Thank you for viewing the detailed overview of Ascendis Health's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Health (JSE:ASC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ascendis Health Ltd (JSE:ASC) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Carey Street, Wynberg, Sandton, GT, ZAF, 2090

Website

https://www.ascendishealth.com

Ascendis Health is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. It has a portfolio of brands and products and owns recognized trademarks in the pharmaceutical and consumer health markets. Ascendis Health has five operating segments: consumer health, pharma, medical, animal health, and biosciences. The pharma division is the contributor to revenue and is further divided into Pharma Africa, Remedica, and Farmalider. Pharma includes generic manufacturing and distribution and over-the-counter medicine manufacturing and distribution. The company's revenue is split between South Africa and Europe and is diversified across currencies, markets, sales channels, and customer groups.